Trial Profile
Treatment of Leishmaniasis With Impavido (Miltefosine): Pregnancy Registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Miltefosine (Primary)
- Indications Leishmaniasis
- Focus Adverse reactions
- Sponsors Knight Therapeutics
- 28 Feb 2017 Status changed from not yet recruiting to recruiting.
- 30 Apr 2015 New trial record